Meet us next:   NIH Research Festival 2024  24 September  •  Safety Pharmacology Society 2024  22-24 September  •  Drug Discovery 2024 - ELRIG  2-3 October  •  The Cell & Gene Meeting on the Mesa 2024  7-9 October (in person) & 10-11 October (virtual)  •  Other upcoming events
REPROCELL Corporate News

Biopta and Proteon publish new research in Journal of Cardiovascular Pharmacology

A new paper in the Journal of Cardiovascular Pharmacology describes a potential treatment for atherosclerosis. Proteon Therapeutics, Waltham, MA, has developed a recombinant pancreatic elastase that was tested for its ability to dilate atherosclerotic human arteries, ethically obtained from patients with peripheral artery disease and set up at Biopta's human tissue research facility in Scotland.

A free download of the article is available at www.ncbi.nlm.nih.gov/pmc/articles/PMC4272232/pdf/jcvp-64-530.pdf

Subscribe to receive updates from REPROCELL

Tagged

Drug Discovery

Stem cell and drug discovery scientists around the world are using our services and products in their preclinical and clinical research.

 More about REPROCELL

REPROCELL Corporate News